The HIV/AIDS Cancer Match Study data provide a valuable resource for cancer epidemiology research. Study data are used for the following purposes:

  1. Identify cancers that occur at increased frequency in HIV-infected people.
  2. Describe changes in cancer burden over time, which may reflect changes in HIV therapy, demographic characteristics such as aging, or other factors.
  3. Describe the spectrum of cancer in subgroups of HIV-infected people of particular interest.
  4. Identify associations with markers of HIV infection status (such as CD4 count and HIV viral load).
  5. Focus on specific cancers (including rare cancers) to identify the effects of immunosuppression and other demographic and medical factors that may reflect etiology.
  6. Identify predictors of cancer outcome.
  7. Provide information for the National Cancer Institute and other policy making bodies on the impact of HIV infection on cancer risk and trends in morbidity and mortality over time.

Ideas for specific projects and collaborations related to these aims are welcome. The HIV/AIDS Cancer Match Study principal investigator is the custodian for the data. Agreements between the National Cancer Institute and participating registries do not allow the National Cancer Institute to share the data with outside investigators. Also, the study data are complex and require the use of sophisticated data handling and statistical modeling techniques. Collaborators can use the study data at the National Cancer Institute under close supervision by the principal investigator, or can participate in analyses through review of tabulated data.

Interested collaborators should contact the HIV/AIDS Cancer Match Study principal investigator:

Eric A. Engels, MD MPH
Infections & Immunoepidemiology Branch
Division of Cancer Epidemiology and Genetics
National Cancer Institute
9609 Medical Center Dr, Room 6E226 MSC 9767
Bethesda, MD 20892
Phone: 240-276-7186
Fax: 240-276-7806